Assessment of screen-recalled abnormalities for digital breast tomosynthesis versus digital mammography screening in the BreastScreen Maroondah trial.

Assessment of screen-recalled lesions showed that, compared with DM, DBT found more benign and more malignant lesions, and generally required more procedures except for less additional mammography workup. These findings show that a transition to DBT screening changes the assessment workload.